<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25184919</article-id>
      <article-id pub-id-type="pmc">4155958</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20143036</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Dermatopathology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Acroangiodermatitis (pseudo-Kaposi's sarcoma) in an HIV sero-positive
patient with syphilis and hepatitis C virus coinfection: clinical and
dermatopathological features<xref ref-type="fn" rid="fn01">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bernardes Filho</surname>
            <given-names>Fred</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martins</surname>
            <given-names>Gustavo</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nery</surname>
            <given-names>Jos&#xE9; Augusto da Costa</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Andrade</surname>
            <given-names>Cec&#xED;lia Vianna</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kac</surname>
            <given-names>Bernard Kawa</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="aff" rid="aff05">5</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> Instituto de Dermatologia Professor Rubem David Azulay - Santa Casa da
Miseric&#xF3;rdia do Rio de Janeiro (IDPRDA - SCMRJ) - Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff02"><label>2</label> Private clinic - Ituiutaba (MG), Brazil.</aff>
      <aff id="aff03"><label>3</label> Funda&#xE7;&#xE3;o Oswaldo Cruz (Fiocruz) - Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff04"><label>4</label> Laborat&#xF3;rio Fonte MD - Niter&#xF3;i (RJ), Brazil.</aff>
      <aff id="aff05"><label>5</label> Laborat&#xF3;rio Anatomical lab - Rio de Janeiro (RJ), Brazil.</aff>
      <author-notes>
        <corresp id="c01"><italic>MAILING ADDRESS:</italic> Fred Bernardes Filho, Rua Marqu&#xEA;s de Caxias, 9,
Sobrado, Centro. 24030-050. Niter&#xF3;i - RJ, Brazil. E-mail:
<email>f9filho@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Sep-Oct</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2014</year>
      </pub-date>
      <volume>89</volume>
      <issue>5</issue>
      <fpage>792</fpage>
      <lpage>795</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>8</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>02</day>
          <month>9</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2014 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>Acroangiodermatitis is an angioproliferative disease usually related to chronic
venous insufficiency, and it is considered a clinical and histological simulator of
Kaposi's sarcoma (KS). Immunohistochemistry is the suitable method to differentiate
between these two entities. It reveals the following immunostaining profile:
immunopositivity with anti-CD34 antibody is restricted to the vascular endothelium in
acroangiodermatitis, and diffuse in the KS (endothelial cells and perivascular
spindle cells); immunopositivity with anti-HHV-8 only in KS cases. We report the case
of an HIV seropositive patient without apparent vascular disease, who presented
violaceous and brownish erythematous lesions on the feet, and whose histopathology
and immunohistochemistry indicated the diagnosis of acroangiodermatitis.</p>
      </abstract>
      <kwd-group>
        <kwd>AIDS Serodiagnosis</kwd>
        <kwd>Herpesvirus 8, human</kwd>
        <kwd>Immunohistochemistry</kwd>
        <kwd>Sarcoma, Kaposi</kwd>
        <kwd>Syphilis, cutaneous</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Acroangiodermatitis is an unsual angioproliferative disease related to chronic venous
insufficiency, arteriovenous malformations or fistulas, paralyzed limbs, amputation
stumps and thrombotic conditions.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup> It is generally characterized by purpuric
macules, papules or plaques on the dorsum of the feet and the malleolus. It is
considered a clinical and histological simulator of Kaposi's sarcoma (KS) and may
present proliferation of endothelial cells, neoformation of thick-walled vessels,
frequently in lobular arrangement and surrounded by pericytes in the dermis,
extravasation of red blood cells, deposition of hemosiderin pigment, dermal fibrosis,
small thrombi in the in the lumen of blood vessels and a superficial perivascular
infiltrate with lymphocytes, histiocytes and occasional plasma cells.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref></sup></p>
      <p>Epidemic KS is the malignancy most commonly associated with acquired immunodeficiency
syndrome (AIDS). It is usually aggressive and causes lesions in the skin and viscera,
with variable progression.<sup><xref rid="r04" ref-type="bibr">4</xref></sup> It may
occur as the first manifestation of AIDS, concomitantly with other manifestations or
late in the course of disease. The clinical presentation of KS is highly variable,
generally beginning with purplish or brownish, erythematous, asymptomatic macules that
later evolve into papules, plaques, nodules or tumor lesions.<sup><xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup></p>
      <p>Histopathologic distinction between acroangiodermatitis and Kaposi's sarcoma is often
difficult due to the overlapping of histological changes depending on the clinical stage
of lesions.<sup><xref rid="r01" ref-type="bibr">1</xref></sup> Immunohistochemistry is a
valuable method to differentiate between these two entities: in acroangiodermatitis CD34
expression is noted only in endothelial cells, whereas in Kaposi's sarcoma it is
identified both in endothelial cells and perivascular spindle cells (<xref ref-type="fig" rid="f01">Figure 1</xref>).<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup> By using the antibody
against the latent nuclear antigen 1 (LNA-1) of human herpes virus 8 (HHV-8) it is
possible to detect the presence of the virus in the tumor cells especially in the
initial lesion -, and differentiate KS from its histological simulators.<sup><xref rid="r06" ref-type="bibr">6</xref></sup></p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>In acroangiodermatitis, initial histological changes such as proliferation of
pericytes and endothelial cells, with formation of lymphatic vessels and
capillaries, cracks in the papillary dermis and extravasation of erythrocytes are
similar to Kaposi's sarcoma. The positivity for CD-30 is found only in the
endothelium, unlike Kaposi's sarcoma, in which positivity is found both in the
endothelium and the pericytes</p>
        </caption>
        <graphic xlink:href="abd-89-05-0792-g01"/>
      </fig>
      <p>The early diagnosis of clinical lesions that simulate KS can be a challenge to
dermatologists who treat HIV seropositive patients. In this study, we present the case
of a HIV seropositive patient with suspected early-stage KS. Immunohistochemistry of two
of his lesions revealed immunonegativity for HHV-8 and CD34 immunopositivity restricted
to endothelial cells.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 41-year-old male patient newly diagnosed with coinfection of HIV-1, HIV-2 and
hepatitis C virus and syphilis infection (VDRL 1:64 and reagent FTA-ABs) presented
violaceous and brownish erythematous macules on the feet with 6 months of evolution. He
denied comorbidities, as well as the use of medications and reported multiple sexual
partners. The patient started antiretroviral therapy with tenofovir, lamivudine and
efavirens indicated by immunodeficiency (CD4 cell count: 152; viral load: 68,800).</p>
      <p>Dermatological examination revealed diffuse erythematous rash, herpes zoster scar in the
left T10-T12 dermatomes, bilateral cracks in the labial commissure, condylomatous
vegetation at the base of the tongue, cervical, axillary and inguinal
micropolyadenomegaly, presence of a single, painless ulcer with elevated borders and
clean base in the glans penis and molluscum contagiosum lesions at the base of the
penis, as well as bilateral palmar erythema and violaceous macules on the right foot and
brownish macules on the left foot (<xref ref-type="fig" rid="f02">Figures 2</xref>,
<xref ref-type="fig" rid="f03">3</xref> and <xref ref-type="fig" rid="f04">4</xref>).</p>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Single, painless ulcer with elevated borders and clean base in the glans penis
(black arrow); molluscum contagiosum lesions at the base of the penis: hypochromic
umbilicated papules (red arrows)</p>
        </caption>
        <graphic xlink:href="abd-89-05-0792-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Violaceous macules on the left foot</p>
        </caption>
        <graphic xlink:href="abd-89-05-0792-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Brownish macule on the right foot</p>
        </caption>
        <graphic xlink:href="abd-89-05-0792-g04"/>
      </fig>
      <p>Lumbar puncture was performed, and the result was: non-reactive VDRL; 100% mononuclear;
50mg% protein; 40 mg% glucose. The patient underwent upper digestive endoscopy and
colonoscopy to determine the stage of disease. Both tests did not evidenced visceral
KS.</p>
      <p>The patient was treated with 3 doses of benzathine penicillin (total dose of 7,200,000 U
IM) with an interval of 7 days between each dose. The chancre completely disappeared
after the three doses of the medication. Biopsies of the lesions on both feet were
obtained. Histopathological examination of the lesion on the left foot showed: presence
of focal proliferation of rounded vessels, small caliber, real lumen, small caliber,
rounded vessels, covered by flattened endothelium in the papillary dermis (<xref ref-type="fig" rid="f05">Figure 5</xref>). Histopathological examination of the
lesion on the right foot revealed: preserved epidermis showing proliferation of
capillaries and "glomeruloid" venules with light ectasia (<xref ref-type="fig" rid="f06">Figure 6</xref>). Immunohistochemistry revealed cells with the following
immunostaining profile: immunopositivity for anti-CD34 antibody only in endothelial
cells and immunonegativity for anti-HHV-8 antibody (<xref ref-type="fig" rid="f07">Figures 7</xref> and <xref ref-type="fig" rid="f08">8</xref>). Histopathological
findings of the two lesions indicate angiodermite de Favre et Chaix. Therefore, the
association of the clinical data with the histological picture and negativity for HHV-8
favor the diagnosis of acroangiodermatitis.</p>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Focal proliferation of rounded vessels, small caliber, real lumen, small-caliber,
rounded vessels, covered by flattened endothelium in the papillary dermis</p>
        </caption>
        <graphic xlink:href="abd-89-05-0792-g05"/>
      </fig>
      <fig id="f06" orientation="portrait" position="float">
        <label>FIGURE 6</label>
        <caption>
          <p>Glomeruloid proliferation of capillaries and venules with light ectasia</p>
        </caption>
        <graphic xlink:href="abd-89-05-0792-g06"/>
      </fig>
      <fig id="f07" orientation="portrait" position="float">
        <label>FIGURE 7</label>
        <caption>
          <p>Immunopositivity with anti-CD34 antibody restricted to the vascular endothelium
(40 x)</p>
        </caption>
        <graphic xlink:href="abd-89-05-0792-g07"/>
      </fig>
      <fig id="f08" orientation="portrait" position="float">
        <label>FIGURE 8</label>
        <caption>
          <p>Vessel proliferation with mild vascular ectasia (arrows) and negative for HHV-8.
(immunohistochemical reaction for HHV-8, 40x)</p>
        </caption>
        <graphic xlink:href="abd-89-05-0792-g08"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The skin is the organ most frequently affected in patients with human immunodeficiency
virus (HIV) infection. The spectrum of mucocutaneous manifestations of HIV infection
includes: infectious processes (viruses, fungi, bacteria, parasites), proliferative
disorders related to the the disturbance of the immune system, neoplastic lesions,
adverse reactions to antiretroviral therapy drugs (HAART) or other
medications.<sup><xref rid="r07" ref-type="bibr">7</xref></sup> Some changes arise
early in the onset of immunodeficiency or during immune reconstitution by HAART.
Prevalence of skin problems during the course of infection may reach 95% and knowledge
of these mucocutaneous manifestations is imperative to all dermatologists.<sup><xref rid="r07" ref-type="bibr">7</xref>,<xref rid="r08" ref-type="bibr">8</xref></sup></p>
      <p>With the advent of AIDS, there was a resurgence in the number of cases of syphilis.
Risky sexual behaviors continue to be the main responsible for this increase.<sup><xref rid="r09" ref-type="bibr">9</xref></sup> Many of the dermatological lesions in HIV
seropositive patients only are found after careful examination and, in some cases,
investigation of immunodeficiency should be mandatory. In our clinical practice, the
overlapping of syphilis stages and molluscum contagiosum lesions in the genital region
has been more frequently observed in HIV seropositive patients.</p>
      <p>Because it makes possible to differentiate neoplastic lesions from their clinical and
histological simulators at an early stage in HIV seropositive patients,
immunohistochemistry has become a great ally to routine techniques. The distinction
between Kaposi's sarcoma and acroangiodermatitis is particularly important, because the
first is an AIDS-defining neoplasia that requires treatment in order to avoid its
dissemination, whereas the latter (acroangiodermatitis) is a non-tumoral,
angioproliferative disorder whose treatment goal is to relieve its symptoms.</p>
      <p>The fact that no evident vascular disorder was found questions the diagnosis of
acroangiodermatitis. However, negativity for HHV-8, acral location, histological picture
of the lesion are features that indicate this diagnosis.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p>Study conducted at the Laborat&#xF3;rio Anatomical lab - Rio de Janeiro (RJ), Brazil.</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Bernardes Filho F, Martins G, Nery JAC, Andrade CV, Kac BK.
Acroangiodermatitis (pseudo- Kaposi's sarcoma) in an HIV seropositive patient with
syphilis and hepatitis C virus coinfection: clinical and dermatopathological
features. An Bras Dermatol. 2014;89(5):792-5.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Cox</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Piette</surname>
              <given-names>WW</given-names>
            </name>
          </person-group>
          <chapter-title>Acroangiodermatitis (of Mali)</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Burns</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Breathnach</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Griffiths</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <source>Rook's Textbook of Dermatology</source>
          <edition>8th</edition>
          <publisher-loc>Oxford</publisher-loc>
          <publisher-name>Wiley Blackwell</publisher-name>
          <fpage>49.17</fpage>
          <lpage>49.18</lpage>
          <year>2010</year>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pimentel</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Cuzzi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Azeredo-Coutinho</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Vasconcellos</surname>
              <given-names>&#xC9;de C</given-names>
            </name>
            <name>
              <surname>Benzi</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Acroangiodermatitis (Pseudo-Kaposi sarcoma): a rarely-recognized
condition. A case on the plantar aspect of the foot associated with chronic venous
insufficiency</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>S13</fpage>
          <lpage>S16</lpage>
          <pub-id pub-id-type="pmid">22068760</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azulay</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Kac</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Cotta-Pereira</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>AFL</given-names>
            </name>
          </person-group>
          <article-title>Acroangiodermatitis (pseudoKaposi's sarcoma)</article-title>
          <source>An Bras Dermatol</source>
          <year>2004</year>
          <volume>79</volume>
          <fpage>193</fpage>
          <lpage>197</lpage>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Aveleira</surname>
              <given-names>JCR</given-names>
            </name>
          </person-group>
          <chapter-title xml:lang="pt">Infec&#xE7;&#xE3;o pelo Herpesv&#xED;rus 8</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Lupi</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Lamy</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Semenovitch</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <source xml:lang="pt">Infec&#xE7;&#xF5;es por Herpesv&#xED;rus</source>
          <publisher-loc>Rio de Janeiro</publisher-loc>
          <publisher-name>AC Farmac&#xEA;utica</publisher-name>
          <fpage>207</fpage>
          <lpage>227</lpage>
          <year>2010</year>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Le&#xE3;o</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Hinrichsen</surname>
              <given-names>Sl</given-names>
            </name>
            <name>
              <surname>Freitas</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Herpes v&#xED;rus humano-8 e Sarcoma de
Kaposi</article-title>
          <source>Rev Ass Med Brasil</source>
          <year>1999</year>
          <volume>45</volume>
          <fpage>55</fpage>
          <lpage>62</lpage>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pereira</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Cuzzi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Galhardo</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical detection of the latent nuclear antigen-1 of the
human herpesvirus type 8 to differentiate cutaneous epidemic Kaposi sarcoma and
its histological simulators</article-title>
          <source>An Bras Dermatol</source>
          <year>2013</year>
          <volume>88</volume>
          <fpage>243</fpage>
          <lpage>246</lpage>
          <pub-id pub-id-type="pmid">23739689</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porro</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Yoshioka</surname>
              <given-names>MCN</given-names>
            </name>
          </person-group>
          <article-title>Dermatologic manifestations of HIV infection</article-title>
          <source>An Bras Dermatol</source>
          <year>2000</year>
          <volume>75</volume>
          <fpage>665</fpage>
          <lpage>691</lpage>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zalla</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>WP</given-names>
            </name>
            <name>
              <surname>Fransway</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
          <article-title>Dermatologic manifestations of human immunodeficiency virus
infection</article-title>
          <source>Mayo Clin Proc</source>
          <year>1992</year>
          <volume>67</volume>
          <fpage>1089</fpage>
          <lpage>1108</lpage>
          <pub-id pub-id-type="pmid">1434871</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Czelusta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yen-Moore</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Van der Straten</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Carrasco</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Tyring</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>An overview of sexually transmitted diseases. Part III. Sexually
transmitted diseases in HIV-infected patients</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2000</year>
          <volume>43</volume>
          <fpage>409</fpage>
          <lpage>432</lpage>
          <pub-id pub-id-type="pmid">10954653</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
